SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-176246
Filing Date
2007-08-09
Accepted
2007-08-09 06:04:13
Documents
8
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 433756
2 RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT dex31.htm EX-3.1 41535
3 SECOND AMENDMENT TO THE REGISTRANT'S AMENDED AND RESTATED BYLAWS dex34.htm EX-3.4 6517
4 AMENDMENT NO. 4 TO THE REGISTRANT'S 2000 STOCK INCENTIVE PLAN dex101.htm EX-10.1 5770
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6501
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6531
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2735
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2765
  Complete submission text file 0001193125-07-176246.txt   507725
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 071037683
SIC: 2834 Pharmaceutical Preparations